Product Information
WELLBUTRIN SR 150 MG TABLET is a brand product labeled by GlaxoSmithKline LLC, priced at $7.5161 per EA under NDC 00173013555. Its NADAC has been published 554 times since Nov 28, 2013.
FDA first approved this application on Oct 4, 1996. Its Orange Book therapeutic-equivalence code is AB1 — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the bupropion hydrochloride market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
150 mg/1
Manufacturer
GlaxoSmithKline LLCNDC
00173013555
Classification
Brand
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
BUPROPION HYDROCHLORIDEApproval Type
New Drug (NDA)
FDA Application
NDA020358FDA Approved
10/4/1996
TE Code
AB1
On Market Since
11/15/1996
Pharmacological Classes
Price Statistics
The NADAC for WELLBUTRIN SR 150 MG TABLET has been published 554 times since Nov 28, 2013, and over the history we have for it it has risen 96.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $7.5161 per EA |
|---|---|
| All-time high | $7.5424 (Apr 16, 2025) |
| All-time low | $3.8183 (Nov 28, 2013) |
| 52-week high | $7.5313 |
| 52-week low | $7.5102 |
| Median price | $7.0955 |
| Average price | $6.5390 |
| Largest weekly change | +15.0% (Jan 14, 2015) |
| Weeks tracked | 554 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 13 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 99% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
GlaxoSmithKline LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
bupropion hydrochloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Aminoketone class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of WELLBUTRIN SR 150 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for WELLBUTRIN SR 150 MG TABLET, manufactured by GlaxoSmithKline LLC, is $7.5161 per EA (NDC 00173013555), effective Sep 30, 2026.
How has the price of WELLBUTRIN SR 150 MG TABLET changed over time?
Over the history we have for it, the NADAC for WELLBUTRIN SR 150 MG TABLET has risen 96.8%. It has been tracked across 554 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for WELLBUTRIN SR 150 MG TABLET?
Since Nov 28, 2013, the NADAC for WELLBUTRIN SR 150 MG TABLET has ranged from a low of $3.8183 (Nov 28, 2013) to a high of $7.5424 (Apr 16, 2025), with a median of $7.0955 per EA.
Are there cheaper alternatives to WELLBUTRIN SR 150 MG TABLET?
Yes. 13 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, BUPROPION HCL XL 150 MG TABLET, is $0.0779 per EA — about 99% below WELLBUTRIN SR 150 MG TABLET.
Who manufactures WELLBUTRIN SR 150 MG TABLET?
WELLBUTRIN SR 150 MG TABLET (NDC 00173013555) is labeled by GlaxoSmithKline LLC, and CMS classifies it as a brand product.